Health
Metformin treatment linked to slowed cognitive decline – WebWire
Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimise their blood glucose levels. A new research study, conducted over six year…
Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimise their blood glucose levels.
A new research study, conducted over six years in the Sydney Memory and Ageing Study in 1037 Australians (aged 70 to 90 years old at baseline), has revealed an additional effect: individuals with type 2 diabetes who used metformin experienced slower cognitive decline with lower dementi…
-
General23 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre
-
General21 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’
-
General13 hours agoPope Francis makes surprise first appearance after hospital stay
-
General20 hours agoDonald Trump and the ghost of Al Capone • Inside Story